Orrstown Financial Services’s Teva Pharmaceuticals TEVA Stock Holding History

Orrstown Financial Services’s Portfolio TEVA Stock Details TEVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-8,756	Closed	-$440K	–	277
2016 Q2	$440K	Sell	8,756 -9,478	-52%	-$505K	0.47%	70
2016 Q1	$976K	Buy	18,234 +2,000	+12%	+$117K	1.05%	48
2015 Q4	$1.06M	Buy	16,234 +2,575	+19%	+$159K	1.15%	35
2015 Q3	$771K	Buy	13,659 +330	+2%	+$21.4K	0.9%	51
2015 Q2	$788K	Buy	13,329 +639	+5%	+$39.4K	0.86%	48
2015 Q1	$790K	Buy	12,690 +1,698	+15%	+$98.7K	0.85%	49
2014 Q4	$632K	Buy	10,992 +6,341	+136%	+$353K	0.67%	53
2014 Q3	$250K	Buy	+4,651	New	+$246K	0.27%	78

Other funds holding TEVA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Orrstown Financial Services's TEVA Position: Q3 2016 in Review

Orrstown Financial Services sold out of Teva Pharmaceuticals (TEVA) in Q3 2016, closing a stake of 8,756 shares — an estimated $440K sold.

Orrstown Financial Services first reported a position in TEVA in Q3 2014 and held it in 8 quarters. The position peaked at $1.06M in Q4 2015. 796 funds tracked by Wall St. Rank hold TEVA as of Q3 2016.

Orrstown Financial Services reported no remaining Teva Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Orrstown Financial Services sold 8,756 Teva Pharmaceuticals shares in Q3 2016, an estimated $440K.
Orrstown Financial Services first reported a position in Teva Pharmaceuticals in Q3 2014 and held it in 8 quarters.
Orrstown Financial Services's Teva Pharmaceuticals position peaked at $1.06M in Q4 2015.
796 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q3 2016.

Based on Orrstown Financial Services's 13F filing for Q3 2016, filed 12 Oct 2016.